news
A Russian compound becomes the first in the world to demonstrate a significant improvement of exercise tolerance among patients with post-COVID lung injury in a multicenter randomized controlled trial
Petrovax Pharm has announced the results of a randomized, double-blind, placebo-controlled study of HA-targeted therapy for post-COVID lung injury
Petrovax Pharm joins industry discussion on expanding access to innovative therapy at Forum in Uzbekistan
Measures to accelerate market access for innovative medicines discussed at SPIEF
RANEPA and Petrovax Pharm to Assess the Pharmaceutical Industry’s Contribution to Russia’s Economic and Scientific Development
Petrovax Pharm and the Union of Russian Pediatricians sign agreement at SPIEF to promote a culture of vaccination
Petrovax Pharm announces support program for women with aggressive breast cancer at SPIEF
Pharma marketing in a new reality: which promotion channels still deliver results
Russian pharmaceutical manufacturers scale up full-cycle production of oncology products and call for faster patient access
Localized full-cycle production of a vital oncology medicine launched in Russia
